TerraBind: Fast and Accurate Binding Affinity Prediction through Coarse Structural Representations
We present TerraBind, a foundation model for protein-ligand structure and binding affinity prediction that achieves 26-fold faster inference than state-of-the-art methods while improving affinity prediction accuracy by $\sim$20\%. Current deep learning approaches to structure-based drug design rely on expensive all-atom diffusion to generate 3D coordinates, creating inference bottlenecks that render large-scale compound screening computationally intractable. We challenge this paradigm with a critical hypothesis: full all-atom resolution is unnecessary for accurate small molecule pose and binding affinity prediction. TerraBind tests this hypothesis through a coarse pocket-level representation (protein C$_β$ atoms and ligand heavy atoms only) within a multimodal architecture combining COATI-3 molecular encodings and ESM-2 protein embeddings that learns rich structural representations, which are used in a diffusion-free optimization module for pose generation and a binding affinity likelihood prediction module. On structure prediction benchmarks (FoldBench, PoseBusters, Runs N' Poses), TerraBind matches diffusion-based baselines in ligand pose accuracy. Crucially, TerraBind outperforms Boltz-2 by $\sim$20\% in Pearson correlation for binding affinity prediction on both a public benchmark (CASP16) and a diverse proprietary dataset (18 biochemical/cell assays). We show that the affinity prediction module also provides well-calibrated affinity uncertainty estimates, addressing a critical gap in reliable compound prioritization for drug discovery. Furthermore, this module enables a continual learning framework and a hedged batch selection strategy that, in simulated drug discovery cycles, achieves 6$\times$ greater affinity improvement of selected molecules over greedy-based approaches.
Code (0)
등록된 구현이 없습니다.
Tasks
Continual LearningDrug DiscoverySimilar Papers 제목 키워드 기반
CoPRA: Bridging Cross-domain Pretrained Sequence Models with Complex Structures for Protein-RNA Binding Affinity Prediction
Accurately measuring protein-RNA binding affinity is crucial in many biological processes and drug design. Previous computational methods for protein-RNA binding affinity prediction rely on either sequence or structure f…
Drug DesignPredictionSPIN: SE(3)-Invariant Physics Informed Network for Binding Affinity Prediction
Accurate prediction of protein-ligand binding affinity is crucial for rapid and efficient drug development. Recently, the importance of predicting binding affinity has led to increased attention on research that models t…
Improved Protein-ligand Binding Affinity Prediction with Structure-Based Deep Fusion Inference
Predicting accurate protein-ligand binding affinity is important in drug discovery but remains a challenge even with computationally expensive biophysics-based energy scoring methods and state-of-the-art deep learning ap…
Computational EfficiencyDrug DiscoveryGraph Neural NetworkPANDA: Predicting the change in proteins binding affinity upon mutations using sequence information
Accurately determining a change in protein binding affinity upon mutations is important for the discovery and design of novel therapeutics and to assist mutagenesis studies. Determination of change in binding affinity up…
Anomaly DetectionToxBench: A Binding Affinity Prediction Benchmark with AB-FEP-Calculated Labels for Human Estrogen Receptor Alpha
Protein-ligand binding affinity prediction is essential for drug discovery and toxicity assessment. While machine learning (ML) promises fast and accurate predictions, its progress is constrained by the availability of r…
Drug Discovery